RU2007135030A - Композиции и способы классификации биологических образцов - Google Patents

Композиции и способы классификации биологических образцов Download PDF

Info

Publication number
RU2007135030A
RU2007135030A RU2007135030/15A RU2007135030A RU2007135030A RU 2007135030 A RU2007135030 A RU 2007135030A RU 2007135030/15 A RU2007135030/15 A RU 2007135030/15A RU 2007135030 A RU2007135030 A RU 2007135030A RU 2007135030 A RU2007135030 A RU 2007135030A
Authority
RU
Russia
Prior art keywords
epitopes
informative
informative epitopes
nisch
presented
Prior art date
Application number
RU2007135030/15A
Other languages
English (en)
Russian (ru)
Inventor
Тумас НОЙМАН (US)
Тумас НОЙМАН
Михис ПОУЛД (US)
Михис ПОУЛД
Original Assignee
Симайнз, Инк. (Us)
Симайнз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Симайнз, Инк. (Us), Симайнз, Инк. filed Critical Симайнз, Инк. (Us)
Publication of RU2007135030A publication Critical patent/RU2007135030A/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
RU2007135030/15A 2005-02-24 2006-02-24 Композиции и способы классификации биологических образцов RU2007135030A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65685905P 2005-02-24 2005-02-24
US60/656,859 2005-02-24

Publications (1)

Publication Number Publication Date
RU2007135030A true RU2007135030A (ru) 2009-03-27

Family

ID=36928007

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007135030/15A RU2007135030A (ru) 2005-02-24 2006-02-24 Композиции и способы классификации биологических образцов

Country Status (11)

Country Link
US (1) US20090075832A1 (cg-RX-API-DMAC7.html)
EP (1) EP1859266A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008532014A (cg-RX-API-DMAC7.html)
KR (1) KR20080003321A (cg-RX-API-DMAC7.html)
CN (1) CN101160524A (cg-RX-API-DMAC7.html)
AU (1) AU2006216683A1 (cg-RX-API-DMAC7.html)
CA (1) CA2598889A1 (cg-RX-API-DMAC7.html)
IL (1) IL185458A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007010349A (cg-RX-API-DMAC7.html)
RU (1) RU2007135030A (cg-RX-API-DMAC7.html)
WO (1) WO2006091734A2 (cg-RX-API-DMAC7.html)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060222656A1 (en) 2005-04-01 2006-10-05 University Of Maryland, Baltimore MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
WO2002094994A2 (en) 2001-05-18 2002-11-28 Mayo Foundation For Medical Education And Research Chimeric antigen-specific t cell-activating polypeptides
EP2502628B1 (en) * 2006-06-23 2016-12-14 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in cancer
WO2008053573A1 (fr) 2006-10-30 2008-05-08 National University Corporation Hokkaido University Remède pour néoplasme malin
TWI494319B (zh) * 2007-02-21 2015-08-01 Oncotherapy Science Inc 表現腫瘤相關抗原之癌症的胜肽疫苗
WO2009029716A1 (en) * 2007-08-28 2009-03-05 Ramot At Tel Aviv University Peptides inducing a cd4i conformation in hiv gp120 while retaining vacant cd4 binding site
TWI466680B (zh) * 2008-08-01 2015-01-01 Oncotherapy Science Inc Ｍｅｌｋ抗原決定位胜肽及含此胜肽的疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
US9855291B2 (en) 2008-11-03 2018-01-02 Adc Therapeutics Sa Anti-kidney associated antigen 1 (KAAG1) antibodies
GB0823366D0 (en) * 2008-12-22 2009-01-28 Uni I Oslo Synthesis
KR101067815B1 (ko) * 2009-02-05 2011-09-27 서울대학교산학협력단 제1형 당뇨병의 신규한 진단 마커
MX2012001746A (es) 2009-08-14 2012-03-21 Univ California Metodos de diagnostico y tratamiento de autismo.
US8075895B2 (en) * 2009-09-22 2011-12-13 Janssen Pharmaceutica N.V. Identification of antigenic peptides from multiple myeloma cells
TWI485245B (zh) 2010-01-25 2015-05-21 Oncotherapy Science Inc 經修飾之ｍｅｌｋ胜肽及含此胜肽之疫苗
SMT201900505T1 (it) 2011-03-31 2019-11-13 Adc Therapeutics Sa Anticorpi contro l'antigene 1 associato ai reni e loro frammenti leganti l'antigene
US10060911B2 (en) * 2011-08-19 2018-08-28 Protagen Aktiengesellschaft Method for diagnosis of high-affinity binders and marker sequences
WO2013031757A1 (ja) * 2011-08-29 2013-03-07 東レ株式会社 膵癌、乳癌、肺癌又は前立腺癌の検出用マーカー及び検査方法
CA2857400A1 (en) 2012-01-09 2013-07-18 Alethia Biotherapeutics Inc. Anti-kaag1 antibodies or antigen binding fragment thereof for treatment of triple negative breast cancer
US20130183242A1 (en) * 2012-01-18 2013-07-18 University Of Connecticut Methods for identifying tumor-specific polypeptides
GB201319446D0 (en) 2013-11-04 2013-12-18 Immatics Biotechnologies Gmbh Personalized immunotherapy against several neuronal and brain tumors
WO2015172843A1 (en) 2014-05-16 2015-11-19 Biontech Diagnostics Gmbh Methods and kits for the diagnosis of cancer
EP3145516A4 (en) * 2014-05-20 2018-06-13 Kiromic, LLC Methods and compositions for treating malignancies with dendritic cells
EP3247407A4 (en) 2015-01-21 2018-08-22 Inhibrx LP Non-immunogenic single domain antibodies
GB201505305D0 (en) * 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
WO2016210137A1 (en) 2015-06-26 2016-12-29 The Regents Of The University Of California Antigenic peptides and uses thereof for diagnosing and treating autism
SI3322734T1 (sl) 2015-07-16 2021-02-26 Inhibrx, Inc. Multivalentni in multispecifični DR5-vezavni fuzijski proteini
MY198087A (en) * 2015-10-05 2023-07-31 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
EP3193173A1 (en) * 2016-01-14 2017-07-19 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Serological autoantibodies as biomarker for colorectal cancer
GB201604458D0 (en) * 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against cancers
DE102016123893A1 (de) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T-Zellrezeptoren mit verbesserter Bindung
AU2018212584B2 (en) * 2017-01-27 2020-12-10 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
CN108948184B (zh) * 2017-05-22 2021-04-23 香雪生命科学技术（广东）有限公司 一种识别衍生自prame抗原短肽的t细胞受体
CN109400697B (zh) * 2017-08-17 2021-04-23 香雪生命科学技术（广东）有限公司 一种识别prame抗原短肽的tcr及其相关组合物
EP3756680A1 (en) * 2019-06-26 2020-12-30 Universitat de Lleida Intermediate filament-derived peptides and their uses
WO2021011636A1 (en) * 2019-07-15 2021-01-21 Geisinger Health COMPOSITIONS AND METHODS OF TREATMENT FOR BREAST CANCER INVOLVING A NOVEL CAPERα-MLL1 COMPLEX
CN110922492B (zh) * 2019-12-18 2022-02-15 重庆医科大学 融合肽、ctp介导的诱导cml细胞免疫应答的dc疫苗及其制备方法
CN111337678B (zh) * 2020-02-21 2023-06-06 杭州凯保罗生物科技有限公司 与肿瘤免疫治疗效果相关的生物标志物及其应用
CN116773798A (zh) * 2023-06-16 2023-09-19 北京三品医疗科技有限公司 多肽的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US20030092009A1 (en) * 2000-11-16 2003-05-15 Kaia Palm Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease
WO2002073209A2 (de) * 2001-03-10 2002-09-19 Affina Immuntechnik Gmbh Verfahren zur identifikation von immunreaktiven epitopen auf proteinen
EP1386155A4 (en) * 2001-04-10 2006-05-10 Univ Leland Stanford Junior THERAPEUTIC AND DIAGNOSTIC USE OF ANTIBODY SPECIFICITY PROFILES
WO2003042357A2 (en) * 2001-09-28 2003-05-22 Incyte Genomics, Inc. Enzymes
EP1578970A1 (de) * 2002-12-23 2005-09-28 Hans-Jürgen Thiesen Human-autoantigene und deren verwendung
US20040219575A1 (en) * 2002-12-26 2004-11-04 Toomas Neuman Methods and compositions for the diagnosis, prognosis, and treatment of cancer

Also Published As

Publication number Publication date
KR20080003321A (ko) 2008-01-07
WO2006091734A2 (en) 2006-08-31
AU2006216683A1 (en) 2006-08-31
US20090075832A1 (en) 2009-03-19
JP2008532014A (ja) 2008-08-14
EP1859266A4 (en) 2010-07-28
CN101160524A (zh) 2008-04-09
CA2598889A1 (en) 2006-08-31
EP1859266A2 (en) 2007-11-28
WO2006091734A9 (en) 2006-10-19
IL185458A0 (en) 2008-01-06
MX2007010349A (es) 2008-04-09
WO2006091734A3 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
RU2007135030A (ru) Композиции и способы классификации биологических образцов
JP2008532014A5 (cg-RX-API-DMAC7.html)
Ratto et al. Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance
Mathiesen et al. Axillary sampling and the risk of erroneous staging of breast cancer: an analysis of 960 consecutive patients
Group Prognostic importance of occult axillary lymph node micrometastases from breast cancers
Wasco et al. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases
ES2568786T3 (es) Detección de células sensibles a antígenos en una muestra
AR046832A1 (es) Ensayos de rastreo y metodos de tratamiento de tumores
NO20072296L (no) Fremgangsmater og systemer for prognose og behandling av faste tumorer
DE602004015626D1 (de) Bei brustkrebs
van Ineveld et al. 3D imaging for driving cancer discovery
Schroeter et al. Deep time paleoproteomics: Looking forward
Holck et al. False-negative frozen section of sentinel lymph node biopsy for breast cancer
Kim et al. Prognostic significance of a micropapillary pattern in pure mucinous carcinoma of the breast: comparative analysis with micropapillary carcinoma
RU2005106841A (ru) Эпитопы т-клеток в эритропоэтине
Wick Metastases to bones
WO2004113574A3 (en) Methods for disease screening
Shao et al. Dissimilar immunohistochemical expression of ERK and AKT between paired biopsy and hepatectomy tissues of hepatocellular carcinoma
Guha et al. New calloporid (Bryozoa, Cheilostomata) species from Tertiary sequences of western Kachchh, Gujarat
Kidd et al. First three sentinel lymph nodes accurately stage the axilla in breast cancer
Lino-Silva et al. Lymph node retrieval in radical gastrectomy: the pathologist alone or the surgeon-pathologist team?
RU2003125666A (ru) Способ диагностики рака предстательной железы
Stevenson et al. Tumor acquisition for biomarker research in lung cancer
Gaiser et al. Automated Analysis of Protein Expression and Gene Amplification within the Same Cells of Paraffin‐Embedded Tumour Tissue
JP2023522358A (ja) 免疫原性応答を誘発すると予測される１つ又は複数のソースタンパク質の１つ又は複数の候補領域を識別する方法及びシステム並びにワクチンを作製する方法

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20100628